TrialInflammatory bowel diseases2012

One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis.

A Barney Hawthorne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.